A number of studies reported associations of TNF␣ (TNF) promoter and TNF receptor II (TNFR2, TNFRSF1B) 
Introduction
Systemic lupus erythematosus (SLE) is a prototype of systemic autoimmune diseases. Although the etiology of SLE is unclear, epidemiological data indicates a substantial contribution from genetic factors. 1 HLA-DRB1 has been extensively studied as a strong candidate gene in numerous association studies, 2 and the contribution of the HLA region has also been demonstrated in linkage studies. [3] [4] [5] [6] Thus far, the association of HLA-DRB1*1501 (DR2) was frequently demonstrated in Caucasians and east Asians, that of DRB1*1503 (DR2) in AfricanAmericans, and that of DRB1*0301 (DR3) in Caucasians of northern and western European ancestry. 2, [7] [8] [9] [10] Because TNF␣ gene (TNF) is located within the HLA region, possible contribution from TNF should be taken into account for the interpretation of the association of HLA region genes with diseases. In lupus-prone mice, reduced TNF␣ production and the protective effect of recombinant TNF␣ replacement against the development of nephritis were demonstrated. [11] [12] [13] Also in humans, it was reported that HLA-DR2 positive individuals produce low levels of TNF␣ and are more prone to lupus nephritis. 14 In addition, development of anti-dsDNA antibody has been reported in a small proportion of patients with rheumatoid arthritis (RA) treated with monoclonal antibody to TNF␣. 15 These findings suggest that reduced level or function of TNF␣ may be associated with SLE.
In contrast, association of TNF promoter −308A, either independently or secondarily to the association with HLA-DRB1*0301, was reported in Caucasians, [16] [17] [18] African Americans 19 and Asians. 20 This allele has also been shown to be associated with higher promoter activity compared with the TNF-308G allele. 21 However, this association and the difference in the promoter activity have not been confirmed consistently by other investigators. 22 In addition, we previously reported association of TNF receptor 2 (TNFR2, TNFRSF1B) allele coding for Arg at position 196 (TNFR2-196R) with SLE in Japanese, 23 but the association was not detected in a casecontrol study in the Caucasians in the UK and in Spain. 24 Association of this allele with SLE has not yet been studied in the United States.
So far, almost all studies of the association of HLA, TNF and TNFR2 genes with SLE have been done using a casecontrol approach, except for one family-based analysis performed in Europe. 7 One of the potential reasons for discrepant results among the studies is the possibility of population stratification associated with the study design using the unrelated cases and controls. To avoid such a problem, we examined the association of HLA-DRB1 and TNF promoter haplotypes in Caucasian SLE families recruited in southern California, using transmission disequilibrium test (TDT). In addition, recently described polymorphisms at −1031, −863 and −857 of TNF, [25] [26] [27] [28] which have already been shown to be associated with Crohn's disease, 29, 30 narcolepsy 31 and non-insulindependent diabetes mellitus, 32 were also analyzed here for the association with SLE. Furthermore, the analysis for TNFR2 position 196 polymorphism was also carried out.
Results
There are five previously described major haplotypes in the promoter region of TNF. 33 We previously designated four haplotypes formed by −1031/−863/−857 SNPs as TNFA-U01 to U04, in the order of the haplotype frequency in the Japanese population. 27, 30, 34 Our preliminary experiments as well as other studies 25, 33 indicated that −308A is observed exclusively on TNFA-U01; therefore, we designated −308A (also called TNF2) as TNFA-U01.2, and the common TNFA-U01 containing −308G as TNFA-U01.1 (Table 1 ). In addition, there are several additional previously described TNF␣ promoter alleles including −574A, −376A, −238A, −163A, and +70A, 22, 26, 35 among which −238A has been shown to be on the TNFA-U04 haplotype 33 ( Table 1) . Table 2 shows the results of TDT in all 91 SLE families. As expected, HLA-DRB1*1501 was significantly more frequently transmitted to the affected offspring (P Ͻ 0.05). On the other hand, no tendency for preferential transmission was detected for DRB1*0301, nor for TNFA-U01.2 which corresponds to TNFA-308A, in this population. TNFA-U01.1 showed a slight tendency of transmission, while TNFA-U03 showed a tendency of nontransmission to the patients, although the difference did not reach statistical significance.
Then the haplotypes formed by HLA-DRB1 and TNF were constructed for each individual using the pedigree data, on the assumption that recombination did not occur between the parents and the offspring, and the results were analyzed with respect to the haplotypes. Significant transmission of DRB1*1501-TNFA-U01.1 haplotype was observed, while haplotypes formed by TNFA-U01.1 and other HLA-DRB1 alleles did not show any transmission distortion, strongly suggesting that the tendency of transmission of TNFA-U01.1 is secondary to that of DRB1* 1501. In accordance with the previous observations, 36 DRB1*0301 was associated with TNFA-U01.2. However, transmission distortion was not observed for the haplotype formed by DRB1*0301 and TNFA-U01.2. In addition, significant transmission was not observed for TNFR2-196R in this population.
We next performed sib TDT analysis using 59 families in which unaffected sibs were available for the study. As shown in Table 2 , none of the alleles or haplotypes showed significant association.
Two affected sibs were present in 16 families, and three affected sibs were present in one family. Using such affected sib pairs, HLA-DRB1-TNF haplotypes were analyzed for linkage. Eighteen affected sib pairs were informative for the identical-by-descent (IBD) analysis. As shown in Table 3 , evidence for significant linkage was not observed, although a tendency for sharing at least one haplotype was noted.
Because SLE is a heterogeneous disease, and because some genes have been reported to be associated with the clinical phenotypes rather than the susceptibility to the disease, the data was also analyzed with respect to the presence or absence of various clinical characteristics. Table 4 shows the data on clinical subsets in which suf-319 Only the clinical subsets with sufficient numbers of subjects for the analysis are shown.
ficient numbers of subjects could be analyzed. Interestingly, transmission of DRB1*1501 and nontransmission of TNFA-U03 were more remarkable in the patients without lupus nephritis compared with patients with lupus nephritis. In addition, DRB1*1501 was significantly more frequently transmitted to the patients with a history of serositis, while TNFA-U03 tended to be more nontransmitted to the patients with a history of malar rash. Transmission distortion was not detected for DRB1*0301, TNFA-U01.2 and TNFR2-196R in any of the subgroups. When the TDT analysis was restricted only to the multiplex families, statistically significant transmission distortion was not observed for any of the alleles, because of the small number of multiplex families (data not shown).
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Discussion
Our present findings confirmed the association of HLA-DRB1*1501 with SLE in Caucasians in the United States, using TDT. In contrast, transmission distortion was not detected for DRB1*0301, which had also been shown to be associated with SLE in a number of case-control studies. Although the reason for such a discrepancy is not clear, one possibility is the ethnic difference. The association of DRB1*0301 was most frequently demonstrated in the Caucasians of northern and western European descent, but studies in southern and eastern European as well as African-origin populations often reported only weak or no association. 2 It is therefore possible that DRB1*0301 and/or TNF-308A contribute to the development of SLE through interactions with other genetic and/or environmental factors present in subsets of Caucasian populations such as of northern or western ancestry. It is also possible that, in the case of DRB1*0301, other gene(s) in linkage disequilibrium with DRB1*0301 in northern and western Europeans are primarily involved. The extended haplotype HLA-A1-B8-TNF-308A−C4A deletion-DRB1*0301, previously shown to be associated with a number of autoimmune diseases, is dominant in such populations, but other haplotypes containing DRB1* 0301 are also frequent in other populations. 37 However, the power of detection of TDT is substantially weaker than that of the case-control study, 38 and therefore the possibility that the number of families was not sufficient to detect association of DRB1*0301 or TNF-308A cannot be excluded.
As for DRB1*1501, significant transmission of DRB1* 1501-TNFA-U01.1 haplotype, but not of the haplotypes formed by TNFA-U01.1 and other DRB1 alleles, excludes the independent role of TNFA-U01.1. Interestingly, TNFA-U03 showed a tendency of preferential nontransmission to the affected offspring, especially in the patients without nephritis. Previous studies reported conflicting results on the promoter activity of TNFA-U03; increased, 25 no change 26 and decreased. 28 We have recently demonstrated that TNFA-U03 has a significant contribution for the genetic susceptibility to Crohn's disease, which is independent of HLA-DRB1. 30 Since TNF␣ is considered to have a disease-promoting effect in Crohn's disease, TNFA-U03 is likely to be associated with elevated promoter activity. Such a possibility supports the hypothesis that TNF␣ may be protective for SLE. In fact, TNFA-U03 was recently demonstrated to show higher binding to the transcription factor OCT-1, compared with the common TNFA-U01.1 allele. 39 In this study, transmission distortion was not observed for TNFR2-196R allele. Association of TNFR2-196R with SLE has been detected in two independent case-control studies in Japanese (reference 23; Morita C and Horiuchi T, personal communication), but not in another study in the Japanese, 40 nor in Caucasians in the British and Spanish populations. 24 It is possible that this association is dependent on the ethnicity. Of note, linkage of 1p36, the chromosomal location of TNFR2, was reported in Mexican-Americans, but not in Caucasians, in one of the genome-wide screenings. 41 As described above, the power of TDT in the detection of association is relatively weak, 38 and the number of families analyzed in this study is admittedly small. HLA-DRB1 high-resolution genotyping requires multiple PCR and hybridization processes for each sample, and more extensive study on a larger number of families was economically unrealistic. Nevertheless, in a genetically heterogeneous population such as the United States, TDT is considered better than the case-control approach to avoid problems caused from population stratification. The families were also analyzed with sib TDT, using genotypic data of the unaffected sibs. Although sib TDT showed a slight tendency of preferential transmission of TNFA-U01.2, none of the association reached significance, probably because of the modest power of sib TDT as compared with conventional TDT. 42 Although the pedigree disequilibrium test (PDT) has been shown to be much more powerful than sib TDT, 43 extended pedigrees ideal for PDT are not included in our current cohort. Therefore, we chose the conventional TDT for most analyses. Another advantage of TDT is that the haplotypes can be determined from the genotypes of the family members, rather than statistically estimated.
In conclusion, significant association of HLA-DRB1* 1501 was confirmed with TDT in Caucasian SLE families recruited in southern California, while that of DRB1*0301 and TNFA-U01.2 (−308A) was not replicated. In addition, a possible protective effect of TNFA-U03 was suggested. Further genetic mapping, especially on the haplotype containing DRB1*0301, as well as the functional studies of TNF promoter alleles, will shed new light on the role of HLA region genes in SLE. 
Materials and methods
SLE families
Ninety-one families with affected offsprings (71 families with both parents, 20 families with one of the parents) were examined. All families were Caucasians, recruited at UCLA. In 59 families, one unaffected sib was also available for the study. In addition, there were two affected sibs in 17 families, and three affected sibs in one family. This study was approved by the Human Subject Protection Committee of UCLA, and Research Ethics Review Committee of the University of Tokyo. The patients were classified according to the American College of Rheumatology criteria for SLE.
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Genotyping HLA-DRB1 typing was performed using PCR-microtiter plate hybridization (MPH), as previously described. 45 TNF genotyping was done using fluorescence resonance energy transfer (FRET) technology 46 using LightCycler (Roche Diagnostics, Mannheim, Germany), according to the manufacturer's instructions. The promoter region of TNF was divided into three fragments, encompassing −1031, −863 and −857, and −308 SNPs, respectively. The genotype was determined from the combination of these three fragments. The primers, probes and experimental conditions for the LightCycler are summarized in Table  5 . The final concentrations of the primers, the fluorescein 321 probes, LCRed probes and MgCl 2 were 0.5 m, 0.2 m, 0.4 m and 4 mm, respectively. PCR amplification was performed for 50 cycles of denaturation (95°C for 0 s), annealing (annealing temperature shown in Table 5 for 10 s), and extension (72°C for the extension time shown in Table 5 ). Genotypes were determined from the meltingcurve analysis. The temperature transition rate was set at 20°C/s for PCR, and at 0.1°C/s for melting-curve analysis. For the determination of haplotypes formed by −863 and −857 SNPs, two different LCRed probes were used. TNFA-863C-LC was used to distinguish CC/CC, CC/CT and CT/CT genotypes, and TNFA-863A-LC was used to distinguish all other genotype combinations.
TNFR2-196M/R genotyping was performed using PCR single-strand conformation polymorphism (SSCP) 23 or LightCycler, using the primers and probes shown in Table 5 . The conditions for the LightCycler analysis are the same as in TNF promoter analysis, except for the annealing temperature, extension time (Table 5 ) and the temperature transition rate for melting-curve analysis (0.2°C/s).
Data analysis
The TDT was performed using McNemar's test. 47 The 2 value was calculated as follows: 2 = (T − NT) 2 / (T + NT)
where T and NT is the number of transmitted and nontransmitted allele, respectively. For TDT, only the first child was chosen for the analysis in the 17 families with two or three affected children. Families with only a single available parent were treated identically with those with both parents, only when the transmission pattern was informative.
Sib TDT was performed as described. 48 The genotypes of all affected and unaffected sibs were used for the analysis.
HLA-DRB1-TNF haplotypes were constructed from the pedigree genotypes, on the assumption that no recombination occurred between the parents and the offspring. The observed haplotypes in the Caucasians were compatible with those previously reported in the Japanese population. 27 
